Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:Acknowledgment to Reviewers
Volume: 6 Issue: 3
Author(s): Bentham Science Publishers
Affiliation:
Export Options
About this article
Cite this article as:
Bentham Science Publishers , Acknowledgment to Reviewers, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2012; 6 (3) . https://dx.doi.org/10.2174/187221412802481766
DOI https://dx.doi.org/10.2174/187221412802481766 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
1
Related Articles
-
Leptin as Clinical Target
Recent Patents on Inflammation & Allergy Drug Discovery Editorial from Editor-in-Chief: Hypoglossal Nerve Stimulation: An Emerging and Futuristic Therapy for Obstructive Sleep Apnea
Current Respiratory Medicine Reviews The Effect of Risk Factor Changes on Peripheral Arterial Disease and Cardiovascular Risk
Current Drug Targets - Cardiovascular & Hematological Disorders Taurine, Bone Growth and Bone Development
Current Nutrition & Food Science The Prothrombotic State in Hypertension and the Effects of Antihypertensive Treatment
Current Pharmaceutical Design Understanding the Pathogenesis, Therapeutic Targets/Drug Action and Pharmacogenetics of Type 2 Diabetes: Is there a Future for Personalised Medicine?
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeted Drug Delivery to Central Nervous System (CNS) for the Treatment of Neurodegenerative Disorders: Trends and Advances
Central Nervous System Agents in Medicinal Chemistry Emerging Targeted Therapies in Metastatic Renal Cell Carcinoma
Current Clinical Pharmacology Mexiletine Metabolites: A Review
Current Medicinal Chemistry Importance of Male Fertility Control in Family Planning
Endocrine, Metabolic & Immune Disorders - Drug Targets Pharmacogenetics Strategies: From Candidate Genes to Whole-Genome Association Analysis. Exploratory or Confirmatory Studies?
Current Pharmacogenomics and Personalized Medicine Effectiveness and Efficiency of Platelet Rich Plasma in the Treatment of Diabetic Ulcers
Current Pharmaceutical Biotechnology A Review of Pharmacological Properties and Toxicological Effects of Adiantum capillus-veneris L.
Current Drug Discovery Technologies Novel Insights into V-ATPase Functioning: Distinct Roles for its Accessory Subunits ATP6AP1/Ac45 and ATP6AP2/(pro) Renin Receptor
Current Protein & Peptide Science A Glycemic Threshold of 90 mg/dl Promotes Early Signs of Atherosclerosis in Apparetly Healthy Overweight/Obese Subjects
Endocrine, Metabolic & Immune Disorders - Drug Targets Radioimmunotherapy of Solid Tumors: Searching for the Right Target
Current Drug Delivery Steroidal Conjugates and Their Pharmacological Applications
Current Medicinal Chemistry The Dialogue Between Endothelial Cells and Monocytes/Macrophages in Vascular Syndromes
Current Pharmaceutical Design Acute Severe Colitis: Infliximab and/or Cyclosporine?
Current Drug Targets Regulation of Angiogenesis and Angiogenic Factors by Cardiovascular Medications
Current Pharmaceutical Design